Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

15 avr. 2010 16h08 HE | Source: Nasdaq, Inc.

Ironwood Pharmaceuticals, Inc. (IRWD) COO and CFO to Ring The NASDAQ Stock Market Closing Bell

ADVISORY, April 15, 2010 (GLOBE NEWSWIRE) -- What: Michael J. Higgins, COO and CFO of Ironwood Pharmaceuticals, Inc. [IRWD],will visit the NASDAQ MarketSite in New York City's Times Square and...
15 avr. 2010 08h00 HE | Source: NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals Reports Positive Data From Exploratory Phase 2 Trial

EMERYVILLE, Calif., April 15, 2010 (GLOBE NEWSWIRE) -- NovaBay Pharmaceuticals, Inc. (NYSE Amex:NBY), a clinical stage biotechnology company developing first-in-class anti-infectives for the treatment...
15 avr. 2010 07h50 HE | Source: Momenta Pharmaceuticals

Momenta Pharmaceuticals Announces Presentation of M402 Preclinical Data at Upcoming AACR Meeting

CAMBRIDGE, Mass., April 15, 2010 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex mixture drugs,...
15 avr. 2010 07h00 HE | Source: Achillion Pharmaceuticals, Inc.

Achillion Presents Data From Studies of ACH-1625 in Hepatitis C at the EASL International Liver Congress

NEW HAVEN, Conn., April 15, 2010 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) today presented data from the Company's ongoing Phase 1 clinical trial of ACH-1625 to treat hepatitis...
14 avr. 2010 08h30 HE | Source: Neptune Technologies & Bioresources Inc

Acasti Pharma Inc. to Showcase at the Cambridge Healthtech Institute and the BioPharmaceutical Strategy Series

LAVAL, Quebec, April 14, 2010 (GLOBE NEWSWIRE) -- Neptune Technologies & Bioressources Inc. ("Neptune") (Nasdaq:NEPT) (TSX-V:NTB) announces that Acasti Pharma Inc. ("Acasti") is a proud sponsor...
14 avr. 2010 08h20 HE | Source: Hooper Holmes, Inc.

U.S. Preventive Medicine(R) Chooses Hooper Holmes Health & Wellness to Help Improve Outcomes and Reduce Health Care Costs

BASKING RIDGE, N.J., Apr 14, 2010 -- Hooper Holmes (AMEX:HH) today announced that U.S. Preventive Medicine, Inc., has chosen the Company's Health & Wellness division to provide a full suite of...
14 avr. 2010 07h30 HE | Source: TG Therapeutics, Inc.

Manhattan Pharmaceuticals Announces Private Placement Final Close at $3.0 Million

NEW YORK, April 14, 2010 (GLOBE NEWSWIRE) -- Manhattan Pharmaceuticals, Inc. (OTCBB:MHAN) today announced the final close of its private placement in which it sold approximately 121 units, including...
14 avr. 2010 07h00 HE | Source: MEDTOX Scientific, Inc.

MEDTOX Scientific Announces First Quarter Results

ST. PAUL, Minn., April 14, 2010 (GLOBE NEWSWIRE) -- MEDTOX Scientific, Inc. (Nasdaq:MTOX) today announced results for the first quarter ended March 31, 2010. MEDTOX achieved a significant increase in...
14 avr. 2010 07h00 HE | Source: Viking Systems, Inc.

3D Video Captured With Viking Systems' Next Generation Visualization System Showcased at the 12th World Congress of Endoscopic Surgery

WESTBOROUGH, Mass., April 14, 2010 (GLOBE NEWSWIRE) -- Viking Systems (OTCBB:VKNG) announced today that video captured during preclinical evaluations of the Viking 3DHD prototype visualization...
13 avr. 2010 12h35 HE | Source: Rexahn Pharmaceuticals, Inc.

Rexahn Pharmaceuticals Announces Phase IIa Study Results of Serdaxin in Major Depressive Disorder (MDD)

NEW YORK, April 13, 2010 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE Amex:RNN), a clinical stage pharmaceutical company developing potential best in class oncology and central nervous...

Page précédente

Page suivante